Cargando…

Mesenchymal Stem Cells Prevent the Rejection of Fully Allogenic Islet Grafts by the Immunosuppressive Activity of Matrix Metalloproteinase-2 and -9

OBJECTIVE: Mesenchymal stem cells (MSCs) are known to be capable of suppressing immune responses, but the molecular mechanisms involved and the therapeutic potential of MSCs remain to be clarified. RESEARCH DESIGN AND METHODS: We investigated the molecular mechanisms underlying the immunosuppressive...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ding, Yunchuan, Xu, Danmei, Feng, Gang, Bushell, Andrew, Muschel, Ruth J., Wood, Kathryn J.
Formato:	Texto
Lenguaje:	English
Publicado:	American Diabetes Association 2009
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2712800/ https://www.ncbi.nlm.nih.gov/pubmed/19509016 http://dx.doi.org/10.2337/db09-0317

Ejemplares similares

Prolonged Survival of Subcutaneous Allogeneic Islet Graft by Donor Chimerism without Immunosuppressive Treatment
por: Hsu, Brend Ray-Sea, et al.
Publicado: (2017)

Subcutaneous nanotherapy repurposes the immunosuppressive mechanism of rapamycin to enhance allogeneic islet graft viability
por: Burke, Jacqueline A., et al.
Publicado: (2022)

Local Dexamethasone Administration Delays Allogeneic Islet Graft Rejection in the Anterior Chamber of the Eye of Non-Human Primates
por: Tun, Sai Bo Bo, et al.
Publicado: (2022)

Mesenchymal stem cells avoid allogeneic rejection
por: Ryan, Jennifer M, et al.
Publicado: (2005)

PEGDA microencapsulated allogeneic islets reverse canine diabetes without immunosuppression
por: Harrington, Stephen, et al.
Publicado: (2022)

IMMUNOSUPPRESSIVE AND GRAFT-REJECTING ANTIBODIES IN HETEROLOGOUS ANTI-LYMPHOCYTIC SERUM
por: Cinader, B., et al.
Publicado: (1971)

RCAN-11R peptide provides immunosuppression for fully mismatched islet allografts in mice
por: Noguchi, Hirofumi, et al.
Publicado: (2017)

Engineered immunomodulatory accessory cells improve experimental allogeneic islet transplantation without immunosuppression
por: Wang, Xi, et al.
Publicado: (2022)

Delayed allogeneic skin graft rejection in CD26-deficient mice
por: Zhao, Xiangli, et al.
Publicado: (2018)

Cartilage degradation is fully reversible in the presence of aggrecanase but not matrix metalloproteinase activity
por: Karsdal, Morten A, et al.
Publicado: (2008)

NKT cells reject islets
por: Van Epps, Heather L.
Publicado: (2005)

In Vivo Immunogenic Response to Allogeneic Mesenchymal Stem Cells and the Role of Preactivated Mesenchymal Stem Cells Cotransplanted with Allogeneic Islets
por: Oliveira, Régis Linhares, et al.
Publicado: (2017)

CELL-MEDIATED CYTOTOXICITY DURING REJECTION AND ENHANCEMENT OF ALLOGENEIC SKIN GRAFTS IN RATS
por: Peter, Hans-Hartmut, et al.
Publicado: (1972)

A machine learning approach to predict pancreatic islet grafts rejection versus tolerance
por: Ceballos, Gerardo A., et al.
Publicado: (2020)

Mesenchymal Stem Cells Enhance Allogeneic Islet Engraftment in Nonhuman Primates
por: Berman, Dora M., et al.
Publicado: (2010)

Rejection of paternal vs maternal fully matched bone marrow grafts in children with thalassemia
por: Ramprakash, S, et al.
Publicado: (2017)

Recipient natural killer cells alter the course of rejection of allogeneic heart grafts in rats
por: Beetz, Oliver, et al.
Publicado: (2019)

A Cannabinoid 2-Selective Agonist Inhibits Allogeneic Skin Graft Rejection In Vivo
por: Jayarajan, Senthil, et al.
Publicado: (2022)

Successful eradication of chronic myeloid leukemia in a child despite allogeneic graft rejection
por: Vuorenoja, Susanna, et al.
Publicado: (2022)

Local immunomodulation with Fas ligand-engineered biomaterials achieves allogeneic islet graft acceptance
por: Headen, Devon M., et al.
Publicado: (2018)

Matricellular proteins and matrix metalloproteinases mark the inflammatory and fibrotic response in human cardiac allograft rejection
por: Vanhoutte, Davy, et al.
Publicado: (2013)

Baricitinib with cyclosporine eliminates acute graft rejection in fully mismatched skin and heart transplant models
por: Abboud, Ramzi, et al.
Publicado: (2023)

Immunosuppressive Effects of Multipotent Mesenchymal Stromal Cells on Graft-Versus-Host Disease in Rats Following Allogeneic Bone Marrow Transplantation
por: Nevruz, Oral, et al.
Publicado: (2013)

A comprehensive flow-cytometric analysis of graft infiltrating lymphocytes, draining lymph nodes and serum during the rejection phase in a fully allogeneic rat cornea transplant model
por: Maenz, Martin, et al.
Publicado: (2011)

Effects of matrix metalloproteinases on the fate of mesenchymal stem cells
por: Almalki, Sami G., et al.
Publicado: (2016)

Redox-Dependent Inflammation in Islet Transplantation Rejection
por: Barra, Jessie M., et al.
Publicado: (2018)

Cellular Immune Responses in Islet Xenograft Rejection
por: Hu, Min, et al.
Publicado: (2022)

Allogeneic grafts of spontaneous canine melanomas and their cell culture strains in neonatal immunosuppressed dogs.
por: Betton, G. R., et al.
Publicado: (1976)

Topical Delivery of Immunosuppression to Prolong Xenogeneic and Allogeneic Split-Thickness Skin Graft Survival
por: Mastroianni, Melissa, et al.
Publicado: (2018)

Protease nexin 1: a novel regulator of prostate cancer cell growth and neo-angiogenesis
por: McKee, Chad M., et al.
Publicado: (2013)

The specificity of rejection and the absence of susceptibility of pancreatic islet beta cells to nonspecific immune destruction in mixed strain islets grafted beneath the renal capsule in the rat
Publicado: (1989)

Prevention of Allogeneic Cardiac Graft Rejection by Transfer of Ex Vivo Expanded Antigen-Specific Regulatory T-Cells
por: Takasato, Fumika, et al.
Publicado: (2014)

Matrix Metalloproteinase-Induced Epithelial-Mesenchymal Transition in Breast Cancer
por: Radisky, Evette S., et al.
Publicado: (2010)

The Role of Matrix Metalloproteinases in the Epithelial-Mesenchymal Transition of Hepatocellular Carcinoma
por: Scheau, Cristian, et al.
Publicado: (2019)

Impact of DSA and immunosuppression minimization on rejection, graft, and patient survival after simultaneous liver–kidney transplantation
por: Dekeyser, Manon, et al.
Publicado: (2022)

Islet allografts expressing a PD‐L1 and IDO fusion protein evade immune rejection and reverse preexisting diabetes in immunocompetent mice without systemic immunosuppression
por: Paul, Pradyut K., et al.
Publicado: (2022)

No Detectable Alteration of Inorganic Allogeneic Bone Matrix Colonizing Mesenchymal Cells: A Step Towards Personalized Bone Grafts
por: Erivan, Roger, et al.
Publicado: (2021)

G-CSF and Exenatide Might Be Associated with Increased Long-Term Survival of Allogeneic Pancreatic Islet Grafts
por: Zoso, Alessia, et al.
Publicado: (2016)

Implantable Immunosuppressant Delivery to Prevent Rejection in Transplantation
por: Anggelia, Madonna Rica, et al.
Publicado: (2022)

The Current Status of Allogenic Islet Cell Transplantation
por: Czarnecka, Zofia, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ki22io4ge9kb38h6drm0n2rmau